Clinical Trial Update: Pembrolizumab Plus Radiotherapy for Advanced Renal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating pembrolizumab combined with radiotherapy for advanced clear-cell metastatic renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Metastatic Renal Cell Carcinoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Clear-cell Metastatic Renal Cell Carcinoma | Phase 2 | Status: UNKNOWN